Evidence map›Paper›PMID 37824082›Full record

ArticleBiomaterials science2023

3D printing microporous scaffolds from modular bioinks containing sacrificial, cell-encapsulating microgels.

Alexis J Seymour, David Kilian, Renato S Navarro, Sarah M Hull, Sarah C Heilshorn

Abstract read
In one paragraph

Article in Biomaterials science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexis J SeymourDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.ORCID http://orcid.org/0000-0002-8354-1325
David KilianDepartment of Materials Science & Engineering, Stanford University, Stanford, CA 94305, USA. heilshorn@stanford.edu.ORCID http://orcid.org/0000-0003-3151-3637
Renato S NavarroDepartment of Materials Science & Engineering, Stanford University, Stanford, CA 94305, USA. heilshorn@stanford.edu.ORCID http://orcid.org/0000-0001-5949-8251
Sarah M HullDepartment of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID http://orcid.org/0000-0002-3741-654X
Sarah C HeilshornDepartment of Materials Science & Engineering, Stanford University, Stanford, CA 94305, USA. heilshorn@stanford.edu.ORCID http://orcid.org/0000-0002-9801-6304

Funding

Injectable Hydrogels to Deliver Gene Therapy for Myocardial InfarctR01HL151997 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2020 to 2023
$1.7M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Injectable Hydrogels to Protect Transplanted Cells from HypoxiaR01EB027666 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, PLANT, GILES · 2019 to 2022
$1.4M
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cellsR01EB027171 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2019 to 2022
$1.4M
Characterization of corneal stromal stem cells encapsulated within bioorthogonally crosslinked collagen gels for delivery to the ocular surfaceF31EY030731 · NEI · STANFORD UNIVERSITY · PI HULL, SARAH · 2019 to 2022
$131k
NEI NIH HHS F31 EY030731NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R01 HL151997NIBIB NIH HHS R01 EB027171NIBIB NIH HHS R01 EB027666
6 · The paper itself

Abstract

Microgel-based biomaterials have inherent porosity and are often extrudable, making them well-suited for 3D bioprinting applications. Cells are commonly introduced into these granular inks post-printing using cell infiltration. However, due to slow cell migration speeds, this strategy struggles to achieve depth-independent cell distributions within thick 3D printed geometries. To address this, we leverage granular ink modularity by combining two microgels with distinct functions: (1) structural, UV-crosslinkable microgels made from gelatin methacryloyl (GelMA) and (2) sacrificial, cell-laden microgels made from oxidized alginate (AlgOx). We hypothesize that encapsulating cells within sacrificial AlgOx microgels would enable the simultaneous introduction of void space and release of cells at depths unachievable through cell infiltration alone. Blending the microgels in different ratios produces a family of highly printable GelMA : AlgOx microgel inks with void fractions ranging from 0.03 to 0.35. As expected, void fraction influences the morphology of human umbilical vein endothelial cells (HUVEC) within GelMA : AlgOx inks. Crucially, void fraction does not alter the ideal HUVEC distribution seen throughout the depth of 3D printed samples. This work presents a strategy for fabricating constructs with tunable porosity and depth-independent cell distribution, highlighting the promise of microgel-based inks for 3D bioprinting.

Indexed as

BioprintingMicrogelsBiocompatible MaterialsGelatinHumansHuman Umbilical Vein Endothelial CellsHydrogelsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsBiocompatible MaterialsGelatinHydrogelsMicrogels

Identifiers

PMID37824082
PMCPMC10842430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.